FEASIBILITY AND SAFETY OF FULL DOSE ANTICOAGULATION THERAPY (ACT) IN CHILDREN TREATED ACCORDING TO DANA-FARBER CANCER INSTITUTE (DFCI) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CONSORTIUM THERAPY PROTOCOLS
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 1, 2014
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- 1114 Paediatrics and Reproductive Medicine (FoR)
- Adolescent (MeSH)
- Anticoagulants (MeSH)
- Antineoplastic Agents (MeSH)
- Child (MeSH)
- Child, Preschool (MeSH)
- Cohort Studies (MeSH)
- Feasibility Studies (MeSH)
- Female (MeSH)
- Hemorrhage (MeSH)
- Heparin, Low-Molecular-Weight (MeSH)
- Humans (MeSH)
- Incidence (MeSH)
- Male (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Precursor Cell Lymphoblastic Leukemia-Lymphoma (MeSH)
- Retrospective Studies (MeSH)
- Thrombocytopenia (MeSH)
- Thromboembolism (MeSH)
published in
- Pediatric Blood and Cancer Journal